Wsa Hq

WS Audiology (WSA) reported 2% organic revenue growth for the fiscal year that ended September 30, 2026, as gains in its consumer-facing businesses offset a decline in wholesale. In a press release, the company said it met its sales and profitability guidance, but expects margins to fall in the coming year after a major U.S. managed care contract expires in January. WSA is the parent group for Signia, Widex, and Rexton hearing aids and operates HearUSA, Hear.com, and TruHearing, among several other hearing-related brands.

Full-year revenue totaled €2.54 billion (US$2.78 billion), down 2% as reported. Currency movements, including a weaker U.S. dollar and Japanese yen, reduced reported growth by four percentage points. Earnings (EBITDA) excluding special items rose to €473 million (US$519 million) from €456 million (US$500 million), lifting the margin from 17.7% to 18.7%. Net profits increased to €19 million (US$20.8 million) from €4 million (US$4.4 million), helped by higher earnings and lower net interest expense.

ADVERTISEMENTad for Signia

“At WSA, we believe that better hearing starts with recognizing that no two people hear the world in the same way,” said WSA CEO Jan Mäkelä in a press statement. “Understanding individual sound preferences opens up a new dimension in personalized hearing care. We have brought this approach to life through several significant innovations and product launches, which have been very well received in the market.”

Our outlook for 2026/27 is impacted by the non-renewal of a large US managed care contract, as previously announced. Excluding this impact, we expect revenue to grow in line with or above the market, with continued improvement in profitability. Although the non-renewal of the contract weighs on our near-term guidance, our disciplined strategy execution and competitive product portfolio provide a solid foundation for long-term profitable growth.

WSA CEO Jan Mäkelä
Jan Mäkelä.
Jan Mäkelä.

Consumer businesses led growth as wholesale stabilized

WSA’s consumer-facing businesses grew 7% organically for the year, with contributions from managed care, retail, and online sales. Wholesale revenue declined 3% organically. WSA attributed the weakness partly to the timing of its product launches relative to competitors. The Americas—which accounted for half of group revenue—grew 3% organically, while sales were flat in Asia-Pacific, Europe, the Middle East, and Africa.

The July-September quarter showed improvement. Group revenue reached €654 million (US$717 million), up 4% organically and 5% as reported. Consumer-facing sales grew 8% organically, while wholesale sales were flat. All three regions returned to organic growth in the quarter, led by the Americas at 5%, followed by Europe, the Middle East, and Africa at 3% and Asia-Pacific at 1%.

WSA credited the launch of Signia MaX with helping sales pick up late in the fiscal year. The platform uses four deep neural networks () to process speech, noise, the listening environment, and the wearer’s own voice. WSA also highlighted Widex Allure AI RIC, which adds an on-demand Clarity Boost feature designed to make conversations easier to follow in noise; however, Allure has not been available in the U.S. until this month. The company expects both platforms and additional hearing aid styles to support sales in 2026/27.

Signia MaX hearing aid.
Signia MaX hearing aid.

U.S. managed care contract weighs on next year’s outlook

WSA expects organic revenue growth of -2% to +2% in fiscal 2026/27 and a decline of about two percentage points in its EBITDA margin before special items. The company estimates that the U.S. managed care contract, which expires on January 1, will reduce group revenue growth by about five percentage points and the margin by about three points. Excluding that impact, WSA expects revenue growth to meet or exceed the broader market and profitability to continue improving. The company projects 3% to 4% growth in global hearing aid unit sales.

ADVERTISEMENTad for Signia

The annual report also addressed the late-October cybersecurity incident that temporarily disrupted some Widex apps. WSA said the incident occurred after the fiscal year closed and that it expects the financial impact to be limited, with no effect on its guidance.

WSA’s 4% organic growth in the July-September quarter came as several peers also reported gains. Over the same 3 months, Demant reported 17% organic growth in hearing aid sales to external customers, GN Hearing posted 5% organic growth, and hearing care retailer Amplifon reported 3.6%. The maker of Phonak and Unitron hearing aids, Sonova, reported 7.5% group sales growth and 11% wholesale hearing instrument growth at constant exchange rates for the 6 months ended September 30. However, direct comparisons are often difficult because the figures cover different reporting periods and reflect different mixes of wholesale hearing aid sales, retail hearing care, and other businesses.

For WSA, the coming year will show how much the new Signia and Widex platforms can contribute as the company absorbs the loss of a large U.S. contract. 

  • Karl Strom

    Karl Strom

    Editor in Chief

    Karl Strom is the editor-in-chief of HearingTracker. He was a founding editor of The Hearing Review and has covered the hearing aid industry for over 30 years.